Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 3.87% is 17% below its 5-year average of 4.68%, near the low end of its 5-year range (3.04%–39.77%).
As of the fiscal period ended Tuesday, June 30, 2026. 20.23% below its 12-month average of 4.85%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.87%.
DEBT TO ASSETS RATIO
3.87%
DEBT TO ASSETS RATIO AVG TTM
4.85%
DEBT TO ASSETS RATIO AVG 3Y
4.44%
DEBT TO ASSETS RATIO AVG 5Y
4.68%
DEBT TO ASSETS RATIO AVG 10Y
3.65%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-20.23%
CURRENT VS 3Y AVG
-12.85%
CURRENT VS 5Y AVG
-17.29%
CURRENT VS 10Y AVG
+6.05%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 834 covered companies
CURRENT VS SECTOR MEDIAN
+4202.01%
vs the sector median at left
Spero Therapeutics, Inc.
Market Cap
$68.32M
Debt to Assets Ratio
3.87%
TTM Avg
4.85%
3Y Avg
4.44%
5Y Avg
4.68%
Market Cap
$67.77M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$67.43M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$67.38M
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$71.19M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$71.23M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | $68.32M | 3.87% | 4.85% | 4.44% | 4.68% |
| Tiziana Life Sciences Ltd (TLSA)vs › | $67.77M | 0.04% | N/A | N/A | N/A |
| iBio, Inc. (IBIO)vs › | $67.52M | 0.02% | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIO)vs › | $67.43M | 0.20% | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR)vs › | $67.38M | 0.33% | N/A | N/A | N/A |
| XBiotech Inc. (XBIT)vs › | $66.46M | 0.00% | N/A | N/A | N/A |
| MindWalk Holdings Corp. (HYFT)vs › | $71.19M | 0.20% | N/A | N/A | N/A |
| Gain Therapeutics, Inc. (GANX)vs › | $71.23M | 0.04% | N/A | N/A | N/A |
| Cingulate Inc. (CING)vs › | $65.46M | 0.19% | N/A | N/A | N/A |
| InterCure Ltd. (INCR)vs › | $65.15M | 0.27% | N/A | N/A | N/A |
Debt/Assets
3.9%
Debt/Equity
0.05
Current Ratio
6.12
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 3.87% |
| 2026-03-31 | 4.19% |
| 2025-12-31 | 4.20% |
| 2025-09-30 | 6.19% |
| 2025-06-30 | 5.82% |
| 2025-03-31 | 5.10% |
| 2024-12-31 | 3.89% |
| 2024-09-30 | 3.42% |
| 2024-06-30 | 3.29% |
| 2024-03-31 | 3.13% |
| 2023-12-31 | 3.04% |
| 2023-09-30 | 5.44% |
| 2023-06-30 | 6.18% |
| 2023-03-31 | 5.67% |
| 2022-12-31 | 5.33% |
| 2022-09-30 | 10.70% |
| 2022-06-30 | 11.00% |
| 2022-03-31 | 39.77% |
| 2021-12-31 | 4.29% |
| 2021-09-30 | 5.00% |
| 2021-06-30 | 6.22% |
| 2021-03-31 | 5.33% |
| 2020-12-31 | 5.11% |
| 2020-09-30 | 5.11% |
| 2020-06-30 | 5.70% |
| 2020-03-31 | 4.96% |
| 2019-12-31 | 5.23% |
| 2019-09-30 | 4.09% |
| 2019-06-30 | 3.96% |
| 2019-03-31 | 4.04% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2016-12-31 | 0.00% |
